Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    Crypto, Cryptocurrencies, Trading and leveraging bitcoin to trade derivatives via CFDs.

    How to Leverage More Crypto Using CFDs

    December 6, 2021
    Startup, Biotricity, Bioflux, Biokit, Bioheart, Samsung Watch4, Waqaas Al Siddiq

    Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest

    July 14, 2021
    All Electric Race Series, Ferrari, Tesla, Worksport, Terravis Energy, Polaris, KULR, Greenland Technologies, KULR, Phoenix Startups, Arizona Startups, StartEngine Startups, Battle Approved Motors, The Battle Ground, BAM, Chris James, Racing, Electric Vehicles, EVs, UTVs, Utility Terrain Vehicles, ATVs, All Terrain Vehicles, Glamping, Racing, NASCAR,

    What is a UTV, and Why Might Investing in BAM be a Good Idea?

    July 22, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    Sales Attribution, Revenue Attribution, Marketing Attribution, Advertising Strategies, Jessica Abraham, Jessica N Abraham

    Experts say you need a Marketing & Revenue Attribution Strategy in 2021. But, do you?

    December 29, 2020
    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding, Team Building, Leadership, Workforce Optimization, Corporate Development, Business Development, Business Expansion, Growth, Team Building, Culture, Building Remote Teams, Compliances, Roles, Infrastructure, Differences in Opinion,

    Turn your consulting energy into coaching revenue

    January 14, 2020
    axs, walter williams sr, ojays, akron ohio, r&B, music, independent artists, new industry cowboys, career development, artist development, fame, industry tips,

    ‘Independents: The Industry Cowboys’ featured insights from Walter Williams, Sr.

    April 7, 2015
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.